单剂量和每日4周的中链甘油三糖剂疗法都能促进年轻人认知功能的某些方面:随机对照试验
I Wayan Yuuki1, Kento Dora2, Teppei Matsumura3
1Faculty of Sport and Health Science, Ritsumeikan University, Shiga, Japan.
Physiology & behavior
|December 24, 2025
概括
中链甘油三酸 (MCT) 在年轻成年人中急性改善了抑制控制. 四周的MCT疗法增强了工作记忆,单剂量反应者通常显示持续的益处.
科学领域:
- 神经科学是一个神经科学.
- 营养科学 营养科学
背景情况:
- 已知抗氧化油,如中链甘油三 (MCT),有利于老年人和神经退行性疾病的认知衰退.
- 然而,它们对年轻人的认知功能的影响以及即时和持续影响之间的相关性尚未得到充分理解.
研究的目的:
- 调查急性和长期中链甘油三酸 (MCT) 消费是否与长链甘油三酸 (LCT) 相比,在年轻人中提高认知功能.
主要方法:
- 一项随机对照试验涉及36名年轻成年人 (21±1岁),分为MCT和LCT (橄油) 组.
- 认知功能,包括记忆,抑制控制 (IC) 和工作记忆 (WM),在急性油摄入和每日干预4周后进行评估.
主要成果:
- 与LCT相比,急性MCT摄入显著改善了抑制控制 (IC) (P <0.05).
- 在4周后,与LCT (P = 0.04) 相比,每日MCT显著增强了工作记忆 (WM).
- 在MCT对认知功能的急性和长期影响之间观察到积极的相关性,表明一致的响应者.
结论:
- 在年轻成年人中,单剂量MCT增强了抑制控制,而每日4周的治疗方案改善了工作记忆.
- 个人对急性MCT摄入的反应通常预测了对慢性消费的反应,这表明个性化的认知益处.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
503
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
503
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Bioavailability Study Design: Single Versus Multiple Dose Studies
176
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
176
Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
Bioavailability Study Design: Healthy Subjects Versus Patients
130
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
130
Atherosclerosis III: Management
291
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
291


